Impact of Peristent Plaque Change after Drug-Eluting Stents Implantation - Comparison between Zotarolimus-Eluting Stents and Paclitaxel-Eluting Stents

被引:0
|
作者
Muraoka, Yoshitaka [1 ]
Sonoda, Shinjo [1 ]
Kashiyama, Kuninobu [1 ]
Anai, Reo [1 ]
Kamezaki, Fumihiko [1 ]
Tsuda, Yuki [1 ]
Araki, Masaru [1 ]
Okazaki, Masahiro [1 ]
Otsuji, Yutaka [1 ]
机构
[1] Univ Occupat & Environm Hlth, Dept Cardiovasc Med, Kitakyushu, Fukuoka 807, Japan
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:B170 / B170
页数:1
相关论文
共 50 条
  • [31] Comparison of sirolimus-eluting stents and paclitaxel-eluting stents in Japanese diabetic patients
    Sawai, Toshiki
    Miyahara, Masatoshi
    Nakata, Tomoyuki
    Nakajima, Hiroshi
    Tamada, Hiroya
    Yamada, Norikazu
    Nakamura, Mashio
    Ito, Masaaki
    ENDOCRINE JOURNAL, 2010, 57 : S380 - S380
  • [32] Vascular Response to Overlapping Everolimus-eluting stents: Comparison with Paclitaxel-eluting Stents
    Otake, Hiromasa
    Ako, Junys
    Yamasaki, Masao
    Tsujino, Ichizo
    Shimohama, Takao
    Hasegawa, Takato
    Sakurai, Ryota
    Waseda, Katsuhisa
    Yock, Paul G.
    Honda, Yasuhiro
    Sudhir, Krishnankutty
    Stone, Gregg W.
    Fitzgerald, Peter J.
    AMERICAN JOURNAL OF CARDIOLOGY, 2008, 102 (8A): : 170I - 170I
  • [33] REGRESSION OF YELLOW PLAQUE BY ENDEAVOR-ZOTAROLIMUS-ELUTING STENTS AND EVEROLIMUS-ELUTING STENTS IMPLANTATION
    Akazawa, Yasuhiro
    Matsuo, Koshi
    Ueda, Yasunori
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E1847 - E1847
  • [35] Comparison of Zotarolimus-Eluting Stents versus Sirolimus-Eluting Stents and Paclitaxel-Eluting Stents for Diffuse Very Long Lesions; A Subgroup Analysis of the Zest 2-Year Follow-up
    Kim, Won-Jang
    Park, Duk-Woo
    Sun, Byung Joo
    Cho, Sung Won
    Kim, Yoo Ri
    Lee, Jong-Young
    Kang, Soo-Jin Kang
    Lee, Seung-Whan
    Kim, Young-Hak
    Lee, Cheol Whan
    Park, Seong-Wook
    Park, Seung-Jung
    CIRCULATION, 2010, 122 (21)
  • [36] Relative performance of zotarolimus-eluting stents vs. sirolimus- or paclitaxel-eluting stents: pooled analysis of six randomized trials
    Pavli, E.
    Dibra, A.
    Mehilli, J.
    Dibra, L.
    Schoemig, A.
    Kastrati, A.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2010, 12 (0F) : F85 - F85
  • [37] Drug-eluting stents and vulnerable plaque
    Cilingiroglu, Mehmet
    Khan, Faisal
    CURRENT ATHEROSCLEROSIS REPORTS, 2009, 11 (02) : 146 - 148
  • [38] Paclitaxel-eluting coronary stents
    Ajani, AE
    Waksman, R
    NEW ENGLAND JOURNAL OF MEDICINE, 2004, 350 (20): : 2099 - 2100
  • [39] Drug-eluting stents and vulnerable plaque
    Mehmet Cilingiroglu
    Faisal Khan
    Current Atherosclerosis Reports, 2009, 11 : 146 - 148
  • [40] Drug-eluting Stents for the treatment of chronic total occlusion. A randomized comparison of rapamycin- versus paclitaxel-eluting stents
    de Lezo, JS
    Medina, A
    Pan, M
    Romero, M
    Segura, J
    Delgado, A
    Hernandez, E
    Ojeda, S
    Pavlovic, D
    Mazuelos, F
    Herrador, J
    CIRCULATION, 2005, 112 (17) : U537 - U538